Pfizer (PFE) Net Margin (2009 - 2026)

Pfizer (PFE) has 18 years of Net Margin data on file, last reported at 0.56% in Q1 2026.

• Net Margin for Q1 2026 came in at 0.56%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 0.05% (up 2.0% YoY), and the FY2025 annual result was 0.04%, down 9.0% from the prior year.
• Net Margin declined to 0.56% in Q1 2026 per PFE's latest filing, from 1.1% in the prior quarter.
• Over five years, Net Margin peaked at 1.1% in Q2 2025 and troughed at 1.81% in Q3 2024.
• A 5-year average of 0.1% and a median of 0.03% in 2022 frame the typical range for Net Margin.
• The sharpest annual moves came in 2022 and 2024: Net Margin jumped 137 bps in 2022, then sank 254 bps in 2024.
• A 5-year view of Net Margin shows it stood at 0.09% in 2022, then tumbled by 716 bps to 0.76% in 2023, then sank by 139 bps to 1.81% in 2024, then surged by 161 bps to 1.1% in 2025, then plunged by 151 bps to 0.56% in 2026.
• Business Quant data shows PFE's Net Margin at 0.56% in Q1 2026, 1.1% in Q2 2025, and 1.81% in Q3 2024.